Neonates are at increased risk of viral encephalopathies that can result in neurological dysfunction, seizures, permanent disability and even death. The neurological damage results from the combined effect of the virus and the immune response it elicits, thus finding tools to facilitate viral clearance from central nervous system (CNS) while minimizing neuron damage remains a critical challenge. Neonatal mice inoculated intraperitoneally with Tacaribe virus (TCRV) develop seizures, hindlimb paralysis and death within 15 days of inoculation. TCRV localizes to the CNS within days of challenge, primarily infecting astrocytes in the cerebellum and brain stem. We show that infection leads to inflammation, T cell and monocyte infiltration into the cerebellar parenchyma, apoptosis of astrocytes, neuronal degeneration and loss of Purkinje cells. Infiltrating antigen-specific T cells fail to clear the virus but drive the disease, as T-cell-deficient CD3ε KO mice survive TCRV infection with minimal inflammation or clinical manifestations despite no difference in CNS viral loads in comparison with T-cell sufficient mice. CD8+ T cells drive the pathology, which even in the absence of CD4+ T-cell help, infiltrate the parenchyma and mediate the apoptotic loss of cerebellar astrocytes, neurodegeneration and loss of Purkinje cells resulting in loss of balance, paralysis and death. CD4+ T cells are also pathogenic inducing gliosis and inflammation in the cerebellum and cerebrum that are associated with wasting and death several weeks after CD4+ T-cell transfer. These data demonstrate distinct pathogenic effects of CD4+ and CD8+ T cells and identify them as possible therapeutic targets.
INTRODUCTION
New World arenaviruses (NWA) (Tacaribe serocomplex) are a growing family of enveloped segmented RNA viruses that include several highly pathogenic members: Junin, Machupo, Guanarito and Sabia viruses that cause hemorrhagic fevers in humans. [1] [2] [3] If untreated, these viruses can cause severe hemorrhagic and neurological manifestations such as confusion, reduced reflexes, convulsions and coma, and have high mortality rates. 4, 5 As with most viral hemorrhagic fevers, current therapy for NWA consists primarily of convalescent sera and supportive care. Availability of immune plasma is limited and antiviral Ribavarin has been used with mixed efficacy and significant adverse responses. 4 Recent efforts focus on the use of monoclonal antibodies either to reduce the inflammation or to neutralize the virus. 6, 7 Neurological symptoms are more common with NWA than with Old World arenavirus infections and about 10% of patients who survive acute infection with NWA develop long-lasting neurological sequelae. 2, 3, 5 Given their high pathogenic potential, human to human transmission, ease of growth in culture, plastic genomic structure and lack of proven effective therapeutic approaches, these viruses have been included in the list of Class 1A potential biowarfare agents by the United States Centers for Disease Control. 5 Improved understanding of the interactions of these viruses with their host, particularly in the CNS, may help design new and more effective treatments for new NWA that protect the nervous system.
Tacaribe virus (TCRV), a member of the Clade B of NWA, is closely related to Junin, the etiologic agent of Argentine hemorrhagic fever, 8 but has a lower pathogenic potential for humans and is therefore more easily amenable to laboratory study. 9, 10 TCRV infects neonatal, but not adult, mice. Following an intraperitoneal (i.p.) challenge, TCRV is only found in the central nervous system (CNS) and is not detectable in peripheral organs 6 days post infection (dpi). 6 The virus localizes primarily to the brain stem and cerebellum, leading to the development of a lethal meningoencephalitis characterized by diminished activity, flaccid hindlimb paralysis, tremors and death 10-15 dpi. 11, 12 TCRV is non-cytolytic and the associated neuropathology is a direct result of the immune response it elicits. 6, 11 This provides a clear model for assessing the contribution of individual immune cell types to pathogenicity during infection. Previous studies showed that blocking tumor necrosis factor alpha (TNF-α) improved survival significantly (100%), despite persisting infection, indicating that the inflammatory process in the CNS is critical to the development of disease. 6 Importantly, mice lacking T cells (thymectomized before day 3 of life, nude nu/nu or RAG nu/nu ) survive TCRV infection despite high titers of virus in the CNS. 6, 11 This indicates that T cells play an important role in pathogenesis although these cells cannot be infected by the virus. 11, [13] [14] [15] Currently the role of T cells in the CNS is an area of intense study, but their precise roles in the context of viral encephalopathy are not fully understood. Recent studies proposing the use of adoptive transfer with antiviral T cells as a possible treatment to clear microglia persistently infected with Old World Clade arenavirus lymphocytic choriomeningitis virus (LCMV) underscore the need to understand the role of T cells in viral meningoencephalitis. 16 This study examines the role that CD4+ and CD8+ T-cell subsets play in the pathogenesis of TCRV-infected neonatal animals, utilizing CD3ε-deficient (CD3ε KO) mice. These mice develop normal thymic architecture, but fail to develop T cells beyond the double-negative stage 3 (DN3) of development (CD3-positive, CD4, CD8 double-negative (CD44 − /CD25+) stage, 17 resulting in a mouse completely deficient in mature T cells. We show here that infected CD3ε KO mice develop a mild inflammation in the CNS but fail to develop disease despite harboring viral titers in the CNS comparable to those of WT control animals. Passive transfer of naïve or memoryenriched (convalescent) total splenic T cells into infected CD3ε KO animals leads to the development of a fatal encephalitis similar to that of infected wild-type animals, confirming the role of T cells in disease. Importantly, while both CD8+ and CD4+ T cells independently infiltrate the parenchyma and cause CNS inflammation resulting in encephalopathy and death, recipients of the different T-cell sub-types differ significantly in their clinical course and underlying pathology. Improved understanding of the role of T cells may help identify therapeutic targets that reduce neurological sequelae of hemorrhagic fevers.
MATERIALS AND METHODS
Mice C57BL/6, C57BL/6 CD3ε − / − and C57BL/6-OT-1-Tg mice used in this study were bred as homozygous breeding pairs (420 generations). C57BL/6 CD3ε − / − (CD3ε KO) were generously provided by Elizabeth Shores (Division of Therapeutic Proteins, FDA, retired). Mice were housed in sterile microisolator cages under 12 h day/night cycle and given food and water ad libitum in the specific pathogen-free, AAALAC accredited animal facility of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (Bethesda, MD, USA and Silver Spring, MD, USA). All animals and experimental protocols were reviewed and approved by the Center for Biologics Evaluation and Research Institutional Animal Care and Use Committee (IACUC).
Virus preparation-TCRV TCRV strain TRVL 11573 was obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) as a suckling mouse brain desiccate and prepared as previously described. 12 Briefly, TCRV was resuspended in 1 ml of water and subjected to three subsequent passages on Vero (African green monkey kidney fibroblast-like; ATCC) cell monolayers, each for 7 days at 37°C. Vero cells were grown in monolayers in Earl's minimum essential (EMEM; ThermoFisher, Carlsbad, CA, USA) media supplemented with 5% fetal bovine serum and 2 mM L-glutamine (ThermoFisher). After each passage, cells and supernatants were frozen and thawed to lyse cells, releasing virus. Cellular debris was pelleted at 500g for 15 min and viruscontaining supernatants were stored at − 80°C. Supernatants obtained from the third infection passage were titrated by endpoint dilution (TCID 50 ) assay on Vero cells monolayers in 96-well plates (see the section Virus quantification).
TCRV infections
All newborn mice were born from pathogen-free parents and inoculated with 2000 × TCID 50 of TCRV in 20 μl of EMEM by intraperitoneal injection, three days after birth (P3) as previously described. 5, 12 Convalescent mice used to generate T cells were inoculated with 2000 × TCID 50 on P7-P10 and boosted with an equivalent dose of TCRV 7 days before harvesting spleens. Age-matched, uninfected mice were used as control animals for all studies. For experiments tracking survival following TCRV infection, mice were monitored daily for indications of pathology. Moribund (unable to access nutrition due to severe paresis and/or respiratory distress) animals were killed in accordance with the IACUC guidelines.
Virus quantification For brain homogenates, infected mice were killed by CO 2 asphyxiation and exsanguinated by transcardiac perfusion. Brains were removed aseptically, placed in 2 ml of cold Roswell Park Memorial Institute (RPMI) media (ThermoFisher) and manually disrupted with ice-cold Tenbroeck glass grinders (Wheaton, Millville, NJ, USA) until uniform homogenates were obtained. The cellular fractions were pelleted by centrifugation at 400g for 15 min. The supernatants were collected and stored at − 80°C prior to virus assay. The pelleted (cellular) fraction was used for flow cytometry analysis (see below).
Infectious TCRV levels were measured as TCID 50 /ml on Vero monolayers using an end-point dilution assay as previously described. 12 Viral RNA in the CNS was measured using quantitative real-time PCR, comparing TCRV-glycoprotein (GP) transcript levels in the CNS to a standard curve as described. 18 Real-time PCR and TaqMan low-density arrays (TLDA) Brains were collected from infected animals that were exsanguinated by transcardiac perfusion with 10 ml ice-cold phosphate-buffered saline (PBS). The brains were then bisected along the longitudinal fissure and an entire hemisphere including the cerebrum, midbrain and cerebellum was flash frozen in liquid N 2 and stored at − 80°C. The frozen tissue was homogenized in 2 ml/half-brain of Trizol reagent (ThermoFisher) and RNA was isolated following the manufacturers' protocol and resuspended in ultra-pure ddH 2 O. The concentration and purity of isolated RNA were determined by spectrophotometry at 260 and 280 nm using a NanoDrop 1000 spectrophotometer (ThermoFisher). To eliminate potential genomic DNA contamination, the DNA-free Turbo kit (ThermoFisher) was used as per the manufacturer's protocol. Reverse transcription was performed on 1 μg of total RNA, using Multiscript High Capacity Reverse Transcriptase (ThermoFisher), as per the manufacturer's protocol, using random primers. The resulting cDNA was diluted 10-fold with ultra-pure water and stored at − 20°C prior to use in real-time TaqMan PCR reactions (ThermoFisher).
Mouse Immune Array TLDA cards (ThermoFisher) were used as per the manufacturers' instructions. Equal volumes of diluted cDNA and 2 × Universal Taqman Master Mix were prepared. This mixture was loaded into the chambers of a Taqman Array card, which was centrifuged to distribute the cDNA throughout the card. Gene expression is expressed as fold-change relative to the indicated controls. Real-time PCR acquisition was performed using a 7900HT Fast real-time PCR machine with SDS 2.4 software or a Viia7 real-time PCR machine using Viia7 software (ThermoFisher). Automatic threshold and end points for each gene were used. Expression of selected genes was validated using individual TaqMan assays. Fold-change in gene expression was determined using the ΔΔCt method, 19 with expression normalized to the expression of the house keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and then expressed as fold increase over the expression in age-matched uninfected controls unless indicated.
Immunofluorescence immunohistochemistry (IF-IHC) and histology Brains were embedded in TissueTek O.C.T (Sakura-Finetek, Torrance, CA, USA) directly ex vivo in TissueTek cryo-molds (Sakura-Finetek), flash frozen in liquid N 2 and stored at − 80°C. Sections (16 μm thick) were cut as indicated using a Leica CM1900 cryostat (Leica Biosystems, Buffalo Grove, IL, USA), thaw-mounted onto SuperFrost-plus microscope slides (ThermoFisher) and then stored at − 80°C until staining. Prior to staining, sections were thawed and dried at room temperature (RT) for approximately 10 min, fixed in freshly prepared 2% paraformaldehyde in PBS for 15 min and permeabilized using 0.2% Tween-20 in PBS for 20 min at RT. Sections were blocked with 5% normal goat serum+1% bovine serum albumin (BSA) in PBS for at least 60 min at RT. Primary antibodies used include rabbit anti-TCRV pAb (generated by ThermoFisher (Pierce)) by immunizing rabbits with heat-killed, sucrose gradient purified TCRV), rabbit antiglial fibrillary acidic protein (GFAP) (Dako, Carpinteria, CA, USA), rabbit anti-ionized calcium-binding adapter molecule 1 (Iba-1) (Wako Chemicals, Richmond, VA, USA); mouse antiNeuN, rabbit anti-Fox2 (EMD Millipore, Billerica, MA, USA); rat anti-CD45, rat anti-CD8 and rat anti-CD4 (BD Biosciences, San Jose, CA, USA). Tissue sections were stained overnight in a humidified chamber at 4°C with primary antibodies diluted with 1% BSA in PBS. The slides were then rinsed with PBS and incubated with the appropriate Alexa-Fluor-conjugated (raised in goat) secondary antibodies, diluted in 1% BSA in PBS (ThermoFisher) for 460 min at RT. For detection of apoptosis, sections were prepared and stained using the ApopTag-FITC Kit (EMD Millipore) as per the manufacturer's protocol. All IF-IHC sections were mounted with ProLong Gold anti-fade mounting media containing 4 0 6-Diamidino-2-Pheylindole (DAPI) (ThermoFisher). Fluoro-Jade B histology staining, which specifically detects neuronal degeneration, 20 was performed as per the manufacturers protocol (EMD Millipore). Fluorescently labeled antibodies were detected at emission wavelengths: 405 (DAPI), 535 (Alexa-fluor 488), 605 (Alexafluor 568) or 680 nm (Alexa-fluor 647). Sections were imaged using a Pannoramic Digital Slide Scanner, using a × 20 objective lens and appropriate filters to detect the wavelengths listed above. The images collected by the scanner were then stitched together to generate an image of the entire section. From these high-resolution scans, images were captured using Pannoramic Viewer software (3DHistech, Budapest, Hungary), and prepared with Adobe Photoshop CC 2015 software.
Quantification of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and Fluoro-Jade B+ staining was determined by selecting five regions of interest per section from two to four different mice. The individual staining channel for Fluoro-Jade and TUNEL (both green channels) was isolated and threshold was applied to isolate the positive signal. The positive signals were counted using the 3D Object counting module (with a size threshold of 30 pixels to eliminate nonspecific specks). This image processing and analysis were performed using the Fiji (Image J) imaging software. 21 
Flow cytometry
The cellular fractions of brain homogenates (see the section Virus quantification) were pooled and resuspended in 30% percoll (GE Life Sciences, Marlborough, MA, USA) in RPMI +25 mM HEPES (ThermoFisher) and underlaid with 1 ml of 70% percoll. After centrifugation at 800g for 30 min, CNS cells were collected from the 30-70% interface, washed in RPMI and isolated by centrifugation at 400g for 10 min. Each experiment represents at least three independent studies performed using brains pooled from four mice.
Nonspecific antibody binding was blocked with a mix of mouse F c block (purified anti-CD16/32; BD Biosciences) and normal mouse serum for at least 15 min. All antibodies (anti-CD45, anti-CD4, anti-CD8, anti-CD62L, anti-CD11b, anti-I-E/I-A (MHC class 2), anti-CD69, anti-CD44 (BD Biosciences)) and anti-F4/80 (AbD Serotec, Raleigh, NC, USA) were directly conjugated with one of the following fluorochromes: fluorescein isothiocyanate, phycoerythrin, peridinin-chlorophyll proteins or alophycocyanin. The cells were incubated with these antibodies for 20 min in FACS buffer (1% BSA in PBS), then washed with FACS buffer, fixed in 2% paraformaldehyde solution and acquired using a FACSCaliber flow cytometer (BD Biosciences). The resulting data were analyzed using FlowJo (version 10) software (FlowJo, LLC, Ashland, OR, USA). Supplementary Figure S1 shows the gates for the T-cell activation markers (CD44 and CD69) set as per isotype controls as well as the strategy for assigning CD45 low and hi cell populations to distinguish CD45hi F4/80+ infiltrating macrophages from CD45lo F4/80+ microglia.
Isolation and transfer of T cells Donor T cells (total T cells, CD8+ and CD4+ T cells)
were isolated from the spleens of adult WT B6 mice by negative selection using the Untouched Mouse T cell, CD8+ T cell or CD4+ T cell isolation kits, respectively (ThermoFisher) as per the manufacturer's protocols. The purity of the isolated cells was confirmed by flow cytometry to be 490% (Supplementary Figure S2 ). 2.0 × 10 6 cells in serum-free RPMI were transferred by intraperitoneal injection into TCRV-infected or uninfected control recipient pups at 7 dpi (P10) in 100 μl volume using a 27G needle. At 15 days post-transfer (dpt), T cells isolated from uninfected animals showed successful reconstitution of the spleen and cervical lymph nodes following total T-cell transfer and infected recipient animals demonstrated similar reconstitution by flow cytometry (Supplementary Figure S3) .
Statistical analysis
The significance for differences in survival was determined by the log-rank test using GraphPad Prism 5.04 (GraphPad Software, La Jolla, CA, USA). Statistical significance for individual gene expression was determined using the ANOVA or t-test using GraphPad Prism 7.0 (Graphpad Software) or Microsoft Excel 2010 (Microsoft Corp, Redmond, WA, USA), respectively.
RESULTS
Extensive cellular infiltration, apoptosis of astrocytes and loss of Purkinje cells in the cerebellum characterizes the lethal meningoencephalitis in TCRV-infected mice Infection of C57BL/6 (B6 WT) neonatal mice at day 3 of life (P3) with TCRV (2000 × TCID 50 i.p.) results in tremors, delayed righting reflex and hindlimb paralysis by 9-10 dpi, followed by death 3-5 days after (13-15 dpi; Figure 1a ). As described previously, 12 at 10 dpi when the CNS viral load averages 10 6 TCID 50 /ml, microscopic examination of the CNS shows submeningeal edema and inflammation in the cerebellum ( Figure 1d ). Additionally, proinflammatory gene expression occurs in the CNS (Figure 1b ), as will be discussed in more detail below. TUNEL-positive apoptotic cells are present in all cell layers of the cerebellum, particularly the granular layer (Figures 1ciii and g ) as compared with uninfected agematched controls, which show levels of apoptosis consistent with the developmental stage ( Figure 1cii ). Of note at 10-15 dpi both the viral antigen and evidence of apoptosis were mostly restricted to brain stem and cerebellum. The clinical signs and histopathology of the cerebellum suggested the apoptosis of neurons; however, IF-IHC with anti-NeuN, a nuclear marker for neurons (except Purkinje cells (PC)) in the cerebellum, shows only limited co-localization with TUNEL+ cells, indicating minimal apoptosis of neurons ( Figure 1ciii and Supplementary Figure S4 ). Iba-1+ cells (microglia/macrophages) were found proximal to some foci of apoptosis but did not co-localize with TUNEL+ staining either. In contrast, TUNEL+ staining located between neurons within the granular layers, proximal to the PC layer (PCL) and within the matrix layer of the cerebellum co-localized with a number of GFAP+ cells as well as with CD45-infiltrating cells. Co-localization and anatomical location suggest that apoptosis is mostly occurring in GFAP+ astrocytes (Figure 1ciii and Supplementary Figure S4 ). This is consistent with previous studies suggesting that TCRV primarily infects astrocytes, especially protoplasmic astrocytes in the granular layers. 12 Purkinje cells are required for balance and infected mice showed irregular gait, delayed righting reflex and reduced balance. Interestingly, although hematoxylin and eosin staining of the CNS indicated a disruption of the Purkinje cell layer of TCRV-infected animals by 10 dpi (Figure 1d ), Fox2+ PC 22 did not stain TUNEL+ (Figure 1e ). However, Fluoro-Jade B staining indicated widespread neuronal degeneration (Figures 1f and g ) 20 and a significant reduction in the number of Fox2+ cells in the PCL of TCRV-infected animals was observed (Figure 1g , Po0.05). Together, these data show that TCRV infection and the inflammatory response it induces result in neuronal degeneration and loss of PC in the cerebellum secondary to apoptosis of neuron-supporting astrocytes in the cerebellum.
T cells and macrophages infiltrate the CNS parenchyma in response to TCRV infection of the CNS Previous studies had established that TCRV is a non-cytolytic virus and that disease required the presence of T cells as mice thymectomized early in life as well as RAG KO mice showed no clinical evidence of encephalitis. 14 To explore directly the role of the immune response in disease we first assessed whether the immune cells infiltrated the CNS of TCRV-infected mice. Flow cytometry of single-cell suspension from the CNS at 10 dpi showed that 20% of microglia (CD45lo; Figure 2ai ) in the CNS have increased expression of MHC class 2 ((H2-Eb1, Class 2; Figure 2ai ), compared with o1% in age-matched uninfected controls. This is consistent with the activation of microglia and the increased levels of interferon gamma (IFNγ). 15, 23 In addition, infected mice showed an increase in infiltrating peripheral immune cells (CD45hi, 20% of live cells), consisting primarily of CD45hi, CD11b + , F4/80 + macrophages (~30% of CD45hi cells; Supplementary Figure S1 ) and CD8+ T cells (~25% of the CD45hi cells; Figure 2aii ). Most infiltrating T cells were CD62L − CD44+ (90% CD8+ and 75% CD4+; Figure 2aii ), whereas greater than 50% of the infiltrating T cells were positive for CXCR3, a receptor for CXCL10/11, and known to drive T-cell responses into the CNS (data not shown and see refs 24,25) . IF-IHC of coronal sections of the cerebellum show at 10 dpi that CD45+-infiltrating cells are not periventricular (data not shown) or meningeal as reported in the acute LCMV encephalitis model, 25 but instead fully penetrate all layers of the cerebellum of TCRV-infected animals ( Figure 2b ).
To gain a better understanding of the response elicited by the virus we examined changes in gene expression in the CNS at the onset of clinical disease (10 dpi) using semiquantitative real-time PCR. The CNS of TCRV-infected mice at day 10 dpi had increased expression of proinflammatory cytokines and chemokines (Figure 1b) , including IFNβ, IL-6, IL-1β, TNF, CXCL10, CXCL11, CCL5 and CCL2, as well as complement component C3 relative to age-matched uninfected controls. The increased expression of β2 microglobulin (β2m), MHC class 2 (H2-Eb1) and co-stimulatory molecules CD80, CD86 and CD40L (Figure 1bii ), combined with an increase in nitric oxide synthase 2 (NOS2) expression and heme oxygenase 1 (Hmox1), suggest there is activation of microglia and/or infiltrating macrophages, which could include M1 (increased Nos2, STAT1) and M2 (increased Hmox1) phenotypes. 26 Lastly, there are significant increases in the expression of T-cell-related genes, including CD3, CD4 and CD8, effector molecules: granzyme B (Gzmb), and perforin 1 (Prf1), as well as cytokines IFNγ and IL-10 (Figure 1bi 
Role of T cells in TCRV immune-mediated pathology
To confirm the role of T cells in the disease, we utilized CD3ε KO mice, which lack functional T cells and, as previously reported, survive TCRV infection 12 despite harboring viral loads similar to those of WT mice (Figure 3ai ). Ten days post infection CD3ε KO mice showed significantly lower expression of genes linked to CNS inflammation, as compared with infected WT controls (Figure 3aii ). Of note, even in the absence of T cells the virus induces low levels of mRNA expression for CCL2, CCL5 and CXCL10, likely secondary to virus-induced type 1 IFN (Figure 3biii ), as well as TNF and C3 at 10 dpi. This modest inflammatory response in the CNS does not result in clinical disease or death (Figure 3bi) .
To confirm the pathogenic role of T cells, infected CD3ε KO pups received total T cells isolated by negative selection on P10 (7 dpi), harvested from: (1) the spleens of uninfected B6 mice, (2) B6 mice that survive TCRV challenge at P7 (convalescent T cells) or (3) OT-1 transgenic (tg) mice. As shown in Figure 3bi , all mice developed similar levels of viral RNA in the CNS; however, only mice receiving naïve or convalescent WT total T cells replicated the disease of WT mice. Mice that received naïve WT total T cells demonstrated reduced activity, tremors and hindlimb paralysis 13-15 dpt, followed by death 3-6 days later, similar to WT animals ( Figure 3bi ). By comparison, mice that received T cells derived from TCRVinfected convalescent mice displayed accelerated pathology developing paralysis 6-8 dpt and dying by 7-10 dpt. In contrast, CD3ε KO mice that received T cells isolated from OT-1 transgenic mice did not develop disease, despite similar levels of viral nucleoprotein (NP) RNA in the CNS (Figure 3bi ), indicating that a virus-specific T-cell response is required for pathogenesis. As expected, CD3ε KO mice that were infected on P3 but did not receive T cells survived the infection. However, when those that received T cells at 30 dpi, 50% of the animals succumbed to encephalitis within 30 dpt, indicating that the T cells can induce CNS damage in persistently infected mice (Figure 3bi ). As expected, neither CD3ε KO mice receiving vehicle only nor uninfected mice receiving WT T cells developed symptoms (Figure 3bi and data not shown).
To characterize further the effect of the T cells, recipients of naïve T cells were killed at 15 dpt, when mice had developed significant neurological symptoms (loss of balance, righting reflex, tremors) or paralysis. Flow cytometry showed that 20-30% of the live cells isolated from CNS of these mice were CD45hi-infiltrating cells, of which approximately 70% were T cells (45-50% CD8+ T cells and 25-30% CD4+ T cells; Figure 3c ). As in WT mice, the CD4+ and CD8+ T cells infiltrated the parenchyma and had an activated phenotype (490% CD44+, CD62L − ; Figure 3c ). Aged-matched, uninfected controls receiving naïve T cells showed only trace CD45hi infiltrates by flow cytometry, consisting primarily of T cells and only very rare CD45+ cells were observed in the parenchyma by IF-IHC (Figure 3civ) .
Assessment of gene expression in the CNS of these mice at 15 dpt showed that infected CD3ε KO mice receiving naïve total T cells displayed increased mRNA expression for genes linked with T-cell infiltration (CD3, CD4, CD8, GzmB, Prf1), inflammation (TNF, IL-1β, IFNγ) and antigen presentation (β2m, H2-Eb1, CD80 and CD86). This pattern of expression was very similar to infected WT mice at 10 dpi (compare Figures 3aii and bii, red lines) . T-cell recipient mice showed higher levels of CCL2, CCL5, CXCL10 and CXCL11 as well as NOS2, C3 and CCR2 RNA expression, indicating the activation of microglia and/or the infiltration of macrophages into the CNS, comparable to that of infected WT mice. (Figure 3bii The results above confirmed that T cells penetrate the parenchyma and play a key role in initiating and amplifying the pathogenic immune response against TCRV infection. Thus, we reasoned that the maturation of the blood brain barrier (BBB) could contribute to the exclusion of lymphocytes and the increased resistance to TCRV meningoencephalitis observed in older mice. To explore this, neonatal CD3ε KO mice were infected with TCRV at P3 and left untreated. Transfer of naïve total T cells (2.0 × 10 6 cells, intravenously) into persistently infected CD3ε KO mice at 5-6 weeks of age resulted in encephalitis and death (50%) by 30 dpt. These results indicate that while the susceptibility to virus infection is limited to neonates (prior to P5), the T-cell driven fatal encephalitis observed following neonatal TCRV infection is independent of age.
Together these data show that TCRV infection elicits a modest inflammatory response characterized by the upregulation of type I IFN, chemokine and proinflammatory cytokine gene expression that is insufficient to induce disease in the CNS. The infiltration of T cells into the parenchyma of the CNS following infection drives inflammation in the CNS, gliosis and apoptosis of non-neuronal cells, neuronal degeneration, and loss in the granular and PCLs, but no reduction in viral load.
Differential pathology induced by CD8+ and CD4+ T-cell subtypes in the CNS
The roles of CD4+ and CD8+ T cells in CNS viral infections vary from pathogen to pathogen. As shown above, both the B6 WT and T-cell recipient models showed a marked preponderance of CD8+ T cells infiltrating the CNS even when there are similar or higher levels of CD4+ T cells in the periphery (Supplementary Figure S3 and unpublished observation) . Therefore, we next explored whether CD4+ T cells are necessary for pathology by transferring purified CD8+ T cells into P10, TCRV-infected CD3ε KO mice (7 dpi). These mice developed ataxia, tremors and paralysis, succumbing to disease by 15-18 dpt (Figure 5a ) reconstituting the clinical disease observed in T-cell sufficient mice. The clinical disease was associated with increased expression of genes linked to the T-cell infiltration (CD3, CD8, CXCR3) and T-cell effector molecules (GzmB, Prf1, IFNg, IL-10), as well as genes associated with microglia activation (antigen presentation genes, H2-Eb1, Nos2, TNF) at 15 dpt (Figure 5b ), as compared with infected CD3ε KO mice that did not receive T cells. Accordingly, microscopic examination of the CNS at 15 dpt showed infiltrating CD8+ T cells at all depths of the CNS parenchyma, and GFAP+ TUNEL+ cells, likely astrocytes, throughout the cerebellum, particularly in the granular layer as observed in infected WT mice (Figures 5d and g ). These mice also showed marked PC loss at the PCL of the cerebellum (Figure 5e ) as well as increased Fluoro-Jade B staining in all cellular layers of the cerebellum (Figure 5f ). Moderate engorgement of the microglia was evident as indicated with Iba-1 staining (mostly localized to the white matter and matrix layers, proximal to the granular layers).
Previous studies in other neural tropic viruses had shown that CD4+ T cells contribute to antiviral responses by producing cytokines and chemokines that enhance CD8+ T-cell function as well as through direct cytotoxic effects. 28 Since CD4+ T cells infiltrate the CNS (Figures 2 and 3) , we next determined whether they played a direct role in the disease. As shown in Figure 6 , transfer of purified CD4+ T cells into infected CD3ε KO mice resulted in a different clinical outcome. These mice did not show signs of encephalitis until 20-25 dpt, when they became lethargic and unresponsive to stimuli with the majority (80%) ultimately succumbing to disease by 30 dpt (Figure 6a) . Interestingly, before developing signs of encephalitis, at 15 dpt, mice that received CD4+ T cells showed upregulation of GzmB, Prf1 and IFN-γ (relative to infected CD3ε KO mice which had not received T cells) similar to that observed in mice transferred with CD8+ T cells (Figure 6b ). However, these mice also showed greater expression for genes linked to macrophage/microglia activation, including costimulatory (CD40, CD86, H2-Eb1, Hmox1) and inflammation (C3, TNF, Nos2, IL-1a, IL-1b) molecules (Figure 6b ), when compared with CD8+ T-cell recipients (Figure 5b) .
IF-IHC at 15 dpt confirmed the presence of CD4+ T cells in the parenchyma of the CNS (Figure 6d) . Indeed, these mice showed no evidence of increase in apoptotic (TUNEL-positive) cells (Figures 6d and g ), neuronal degeneration (Figure 6f) or loss of PC (Figure 6e ). Instead, CD4+ T-cell recipients showed an anatomically diffuse increase in Iba-1 bright, activated microglia/macrophage staining throughout the cerebellum, with a moderate increase in GFAP staining, indicating widespread activated microglia (Figure 6d ) instead of the localized gliosis observed in CD8+ T-cell recipients and WT animals.
Lastly, as mice that received CD4+ T cells do not succumb until 20-30 dpt, we next examined whether the absence of neuronal degeneration and apoptosis in CD4+ T-cell recipients was due to slower disease kinetics or reflected a difference in pathobiology. IF-IHC at 28 dpt, when the animals became lethargic and hunched, did not show an increase in TUNELpositive cells or significant loss of PC or neurodegeneration in the cerebellum despite persistently TCRV-infected cells (Figure 7) . Surprisingly, by this time we did not observe an increase in cerebellum microgliosis despite the continued presence of some CD4+ T cells and virally infected cells.
Instead, by day 28 the viral antigen was detected with a polyclonal anti-TCRV antibody in more rostral regions of the CNS, particularly the cerebral cortex and hippocampus, and was associated with extensive gliosis (increased Iba-1 and GFAP staining) (Figure 7) . Small numbers of CD4+ T cells were evident in these regions. Lastly, by 28 dpt, there was no increase in TUNEL+ cells but foci of degenerative neurons were evident in the cortex and hippocampus by Fluoro-Jade B staining.
Combined, these data suggest that CD8+ T cells, which are the predominant T-cell population in the CNS responding to TCRV infection, mediate apoptosis of astrocytes and rapid neuronal cell loss, even in the absence of CD4+ T-cell help, and are largely responsible for the acute death observed in T-cell replete mice. In contrast, mice that only receive CD4+ T cells survive longer, but the persistent TCRV infection eventually spreads rostrally, leading to widespread inflammation and gliosis. This inflammation was associated with non-apoptotic neuronal degeneration in several regions of the CNS, particularly the cerebral cortex and hippocampus. As such, acute and subacute TCRV encephalitis may require distinct therapeutic approaches to reduce tissue damage and prevent mortality.
DISCUSSION
For decades, the CNS was considered an immunologically privileged site that kept lymphoid cells beyond the blood brain barrier and was devoid of lymphatics. We now know that glial cells (astrocytes and microglia) armed with a full complement of innate immune receptors constantly surveil the CNS environment, acting as innate immune sentinels of injury or infection and are capable of antigen presentation. Further, lymphatic structures embedded in the dura mater sinuses drain antigen from the CNS into the deep cervical lymph nodes and provide a path for peripheral immune cells to sense and respond to CNS antigens. 29 Lastly, lymphocytes penetrate the BBB in response to cytokine and chemokine production in the CNS following infection and are critical for viral clearance. [30] [31] [32] These factors suggest that adoptive immunotherapies or cytoimmunotherapies could be effective in combating entrenched viral infections of the CNS. 16, 33, 34 While this approach has proven successful in neonatal models of LCMV Armstrong infections, the consequences in other CNS viral infections are not fully understood. Preventing damage to irreplaceable terminally differentiated neurons during infections, infarcts and other injuries of the CNS requires a precise balance between proinflammatory and anti-inflammatory mechanisms. 35 Thus understanding the role immune cells play in the balance between effective viral clearance and neurological damage is critical to the development of these therapies.
Our studies show that early on arenavirus TCRV infects predominantly astrocytes in the cerebellum and brain stem, suggesting that this causes secondary neurodegeneration and loss of cerebellar neurons, most notably Purkinje cells. As is the case with other arenavirus infections, such as the well-studied LCMV model, our studies confirm that this pathology is not mediated directly by the virus, which is non-cytolytic, and in the absence of T cells TCRV only elicits a mild inflammatory reaction of the meninges 36 and the majority of animals live a normal life span. Instead as shown above, TCRV pathogenesis requires antigen-specific T cells that infiltrate the cerebellar parenchyma, leading to an increase in the expression of inflammatory cytokines and cytolytic proteins as well as activation of glial cells, particularly microglia. Interestingly, although the CNS is predominantly infiltrated by CD8+ T cells, both CD4+ and CD8+ T cells independently drive a lethal encephalitis, albeit via different mechanisms.
CNS infiltration by cytolytic CD8+ T cells in response to TCRV infection is associated with increased expression of perforin and granzyme B resulting in the apoptosis of astrocytes and a concomitant degeneration of cerebellar neurons, with consequent reduction in the number of Purkinje cells and other neurons of the granular layers. In contrast, the same infection in mice bearing only CD4+ T cells results in higher expression of proinflammatory genes with diffuse increase in Iba-1+ and GFAP+ cells, suggesting gliosis throughout the CNS concomitant with neural degeneration in the absence of increased apoptosis. These results differ from those in the intracerebral model of LCMV infection, where CD4+ T cells, in the absence of CD8+ T cells, induce a non-fatal encephalitis marked by reduced body weight and increase malaise. 37, 38 In the TCRV model used here, intraperitoneal challenge is followed by a transient peripheral infection that is undetectable by 6 dpi, after which infectious virus is found exclusively within the CNS 12 (unpublished observation), and primarily but not exclusively within GFAP+ cerebellar astrocytes. Importantly, unlike other arenavirus such as LCMV, TCRV resides exclusively in the CNS and does not spread systemically even in severely immunocompromised mice (see Pedras-Vasconcelos et al. 39 and unpublished observation). While several TCRV receptors that could mediate cell entry have been recently proposed, 40, 41 neither the route by which TCRV enters the CNS nor the factors defining its tropism to the CNS has been defined. Our results showing that persistently infected, yet asymptomatic, adult CD3ε KO mice develop acute encephalitis and die following a T-cell transfer confirm that T cells are necessary for pathology. However, the determinants for the selective susceptibility to infection of the neonatal CNS are still unclear. One possibility, as reported for other viruses such as non-neurotropic Sindbis Virus A339, is that infection requires receptors expressed selectively in the immature CNS. 42, 43 However, our studies show that as the disease progresses the virus spreads to infect the cortex and hippocampus and the cells harboring the virus broadens to include neurons ( Figure 7 ). This indicates that the virus can infect fully mature cells in the CNS and the limitation to infecting immature cells is restricted to the initial infection. Alternatively, the increased susceptibility in neonatal mice may be linked to a relatively lower IFN response; however, in our hands adult IFNAR KO mice are not susceptible to peripheral TCRV infection (data not shown). Of note, the virus does not infect T cells and thus these cells are neither a reservoir for infection nor a vehicle for CNS infection. Further studies will be required to fully understand the selective tropism of TCRV.
The cerebellum is involved not only with balance and posture but also with emotions, language and cognition. In patients, cerebellar pathology has been associated with ataxia as well as autism and schizophrenia. 44 Further histopathological findings show reduced number of Purkinje cells in subjects with autism. 45 Our studies and others have shown that TCRV, like Borna disease virus (BDV) and LCMV, infects the cerebellum resulting in neurological sequelae. 15, 46 Interestingly, WT mice infected with TCRV (as well as CD3ε KO-infected mice that received CD8+ T cells) show reduced number of neurons in the granular layers and loss of PC. This is similar to what was described in BDV-infected rats, but unlike BDV, viral antigen was evident primarily in astrocytes and only rare staining for viral antigen was evident in the neurons. 15 , 46 The precise mechanism of virus-induced neuronal loss remains unclear, but the absence of tissue damage in mice lacking T cells strongly suggests that the virus does not trigger cell death directly or indirectly by depriving growing neurons of trophic factors crucial for survival. Instead, like in LCMV, the immune and inflammatory response to the virus appears to mediate the damage. Of note, the infiltrating T cells did not localize to the area of missing PC and apoptotic PC were not observed ( Figures 2, 4 and 5) , suggesting that the reduction in PC may be secondary to changes in the CNS microenvironment that result in neurotoxicity or dysregulation of neuroprotective astrocytes and/or microglia.
T cells reduce the susceptibility of mice to many CNS viral infections such as measles and West Nile virus; [47] [48] [49] [50] [51] however, T-cell-mediated damage to the CNS has been described in LCMV and BDV. 52, 46 The studies presented here show that TCRV infection in T-cell sufficient animals results in significant infiltration of T cells and monocytes into the parenchyma of the CNS, while T-cell-deficient mice (CD3ε KO) develop only a mild inflammation with marginal increases in the expression of chemokines and proinflammatory cytokines (Figure 3aii ). The reconstitution of T-cell populations in CD3ε KO animals using naïve WT T cells, but not OT-1 T cells (Figure 3b ), rescued pathology in recipient mice confirming that the pathogenic T cells must be TCRV specific. This is supported by the observed decreased time to disease onset and increased death rate of animals that received T cells isolated from convalescent WT mice as compared with mice that received naïve T cells (Figure 3bi ). This is consistent with the presence of an expanded population of virus-specific T cells in splenocytes isolated from the convalescent animals, whereas a virus-specific response must develop in naïve T-cell donor populations. As expected, however, the pattern of gene expression in the CNS of the infected recipients at the peak of disease (unpublished observation) was similar between naïve and convalescent T-cell recipients, indicating that the memory and naïve T cells mediate similar pathological changes.
In infected WT mice and CD3ε KO T-cell recipients, activated CD8+ T cells were the dominant subtype found in CNS even if there was a 1:2, CD8+:CD4+ ratio in the donor population (Supplementary Figure S2) , or a 1:1, CD8+:CD4+ ratio of T cells in the reconstituted draining cervical lymph nodes (Supplementary Figure S3) . These data suggest that as reported in LCMV-infected mice, CD8+ T cells are preferentially attracted to the CNS in response to TCRV infection (Figures 2 and 3d) . 52 However, whereas in LCMV infection the infiltrating T cells localized to the cerebral-spinal fluid, meninges and periventricular areas of the brain, 54, 55 TCRV infection causes infiltrating T cells to penetrate all layers of the cerebellum, supporting a direct cytolytic response that underlies the observed tissue damage. Unlike other models of viral encephalitis such as vaccinia or herpes, where CD4+ T cells are required for the activation and maturation of cytolytic CD8+ T cells 56, 57 with TCRV the transfer of purified CD8+ T cells was sufficient to induce tremors, paralysis and death without significant delay relative to those animals that received both T-cell subsets. These mice showed increased CXCR3, IFNg, Gzmb, Prf1 and TNF in the CNS, consistent with the infiltration of cytolytic effector T cells and IHC staining showed evidence of apoptosis of astrocytes with concomitant neurodegeneration and loss of PC that was indistinguishable from that of mice that received total T cells. It is possible that sustained IFN-β expression may contribute to CD8+ T-cell function in the absence of T-cell help, 58, 59 as TCRV differs from other arenaviruses in that its NP does not inhibit type I IFN production 60 and we observe IFN-β and interferonstimulated gene expression at 15 dpt of total T cells (Figure 3biii ). Together, these data suggest that CD8+ T cells are the primary effector cell in the fatal encephalitis that follows TCRV infection and their pathogenic role in the CNS is independent of CD4+ T-cell help.
Compared with our understanding of the cytolytic function of CD8+ T cells, the pathogenic role of CD4+ T cells in neural tropic infections is not as well defined. 61, 62 In LCMV, McGavern et al. 63 showed T-cell-produced IFN-γ is required to recruit monocytes and to activate microglia to the CNS, which leads to increased inflammation and CD4+ T-cellmediated non-fatal wasting disease in the absence of CD8+ T cells. 63 In TCRV-infected WT mice we showed increased expression of T-bet and IFNγ, but not in IL-17 or IL-4, suggesting that the CD4+ T cells infiltrating the CNS in response to TCRV belong to the T H 1 subtype. Further, there was a minimal increase in IL-10 and no change in Foxp3 transcripts in the CNS, suggesting that CD4+ regulatory T cells (T reg ) do not infiltrate the CNS. The absence of T reg in TCRVinfected CNS was confirmed using transgenic mice expressing EGFP under the control of the FoxP3 promoter (FoxP3:EGFP; unpublished observation). Infected CD3ε KO mice that received purified CD4+ T cells showed significant upregulation of genes linked to cytotoxicity (Prf1, Gzmb, IFNγ), activated APC (H2-Eb1, CD86, CD40) and inflammation (C3, Sele, Nos2, TNFa, Il-1b) that were associated with extensive microgliosis of the cerebellum at 15 dpt. Remarkably, despite the increase in markers of inflammation the mice remained asymptomatic until about 1 month post-transfer. Only when the virus had spread to the frontal cortex and hippocampus, showing evidence of extensive astrogliosis and neurodegeneration, did the wasting disease became clinically evident and CD4+ T-cell recipients died. The extensive microglial activation, persistent viral infection and inflammation observed in these mice recalls the pathology observed in other persistent CNS infections, such as patients chronically infected with HIV. 64 There is an increasing body of work indicating that chronically activated microglia, regulated by CD4+ T cells, can result in neurodegeneration through the chronic secretion of factors such as TNF, NO and IL-1β 65, 66, 67 Given the absence of the apoptosis observed when only CD4+ T cells are present in the CNS, it is likely that the observed neurodegeneration in CD4+ T-cell recipients is the result of gliosis mediated cytotoxicity. The precise molecules and mechanisms involved in this CD4+ T-cell-mediated neurodegeneration are currently under investigation.
It is well established that several chemokines including CXCL10 mediate the recruitment of peripheral cells including macrophages to the CNS. Macrophages and microglia are a critical source of TNF. Previous studies had shown that in TCRV or BDV encephalitis, TNF plays a key role in disease pathogenesis and blocking TNF prevented death even in the absence of viral clearance. 15, 68 We show that in the absence of T cells the expression of chemokines and subsequent macrophage infiltration is significantly reduced and CD45lo microglia do not express detectable levels of MHC class 2, NOS2 or co-stimulatory CD80 and CD86. Further, there is no evidence of microgliosis with Iba-1 staining despite increased expression of CCL2, CCL5 and CXCL10. Thus, in the absence of T cells, TCRV infection is insufficient to attract myeloid cells from the periphery or activate brain-resident APCs in the CNS (Figure 3 and data not shown). 63, 69, 70 Therefore, although CD3ε KO mice have an intact myeloid compartment it is not possible to discern the relative contribution of macrophages, microglia and cytotoxic T cells to the disease. Future work using conditional CD11b KO animals will allow us to explore what role, if any, microglia/macrophages play in TCRV encephalitis.
Together, these data show that peripheral challenge with TCRV results in a lethal meningoencephalitis in immunocompetent neonatal mice that is dependent on the infiltration of antigen-specific effector T cells into the CNS. Activated CD4+ and CD8+ T cells can mediate neurological damage and death independently. CNS infiltration with antigen-specific cytolytic CD8+ T cells is associated with apoptosis of GFAP+ astrocytes and loss of granular layer neurons and Purkinje cells in the brain stem and cerebellum. The lethal meningoencephalitis mediated by CD4+ T cells has a slower clinical course and is not associated with apoptosis of the astrocytes. Instead, CD4+ T cells are associated with a T H 1 profile and the recruitment and activation of macrophages/microglia resulting in extensive microgliosis. These data demonstrate that developing therapies that modulate T-cell responses to viral infections in the CNS may be critical in attenuating the clinical course and reducing the neurodevelopmental complications associated with some viral encephalitis and attempts to use T cells as immunotherapeutics should be done with caution.
